Cargando…
The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
BACKGROUND: Hepatocellular carcinoma is the most common cause of primary liver neoplasms and is one of the main causes of death in patients with liver cirrhosis. High Alpha fetoprotein serum levels have been found in 60–70% of patients with Hepatocellular carcinoma; nevertheless, there are other cau...
Autores principales: | Arrieta, Oscar, Cacho, Bernardo, Morales-Espinosa, Daniela, Ruelas-Villavicencio, Ana, Flores-Estrada, Diana, Hernández-Pedro, Norma |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803796/ https://www.ncbi.nlm.nih.gov/pubmed/17288606 http://dx.doi.org/10.1186/1471-2407-7-28 |
Ejemplares similares
-
Intrahepatic Cholangiocarcinoma in a Patient with Alcoholic Liver Cirrhosis and Markedly Elevated Serum Alpha-Fetoprotein
por: Romero, Ana L., et al.
Publicado: (2023) -
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018) -
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
por: Gilabert, Marine, et al.
Publicado: (2018) -
Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
por: Yen, Yi-Hao, et al.
Publicado: (2023) -
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma
por: Manuc, Daniela, et al.
Publicado: (2020)